- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03795766
Nausea and Vomiting After Gynecologic Surgery
January 4, 2019 updated by: Lei Li, Peking Union Medical College Hospital
Prevalence and Predictors of Nausea and Vomiting After Gynecologic Surgery: a Cross-section Study
In this cross-section study, all patients in the gynecologic ward of Peking Union Medical College Hospital will accepted a survey about the prevalence and severity of nausea and vomiting according to visual analogue scale and WHO classification.
Epidemiological, surgical, anaesthetic characteristics and post-operative treatment are considered as predictors for the post-operative nausea and vomiting.
The primary objective is the incidence of nausea and vomiting.
The secondary objective is the possible predictors of nausea and vomiting.
Study Overview
Status
Unknown
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
1000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100730
- Recruiting
- Lei Li
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
All patients accept elective surgeries for gynecologic disease with good performance status.
Description
Inclusion Criteria:
- Aged 18 years or older
- Elective surgeries for gynecologic disease
- Good performance status
- Signed an approved informed consents
- Post-operative stay 72 hours or longer
Exclusion Criteria:
- Emergency surgeries
- Not meeting all of the inclusion criteria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of post-operative nausea and vomiting
Time Frame: 72 hours post-operative
|
Incidence of post-operative nausea and vomiting
|
72 hours post-operative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Severity of post-operative nausea and vomiting by visual analogue scale
Time Frame: 72 hours post-operative
|
Severity of post-operative nausea and vomiting according to the visual analogue scale.
In th scale, 0 denotes none, 10 denotes the most severe conditions.
The scale will be judged by the patients.
|
72 hours post-operative
|
|
Severity of post-operative nausea and vomiting by World Health Organization classification
Time Frame: 72 hours post-operative
|
Severity of post-operative nausea and vomiting according to World Health Organization (WHO) classification.
In WHO classfication, I denotes none, II, III and IV denote mild, moderate and severe conditions.
|
72 hours post-operative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 1, 2019
Primary Completion (ANTICIPATED)
January 1, 2020
Study Completion (ANTICIPATED)
January 1, 2021
Study Registration Dates
First Submitted
January 3, 2019
First Submitted That Met QC Criteria
January 4, 2019
First Posted (ACTUAL)
January 8, 2019
Study Record Updates
Last Update Posted (ACTUAL)
January 8, 2019
Last Update Submitted That Met QC Criteria
January 4, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GY-PONV
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.